Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bilateral breast cancer.

A J Donovan1

  • 1University of Southern California School of Medicine, Los Angeles.

The Surgical Clinics of North America
|October 1, 1990
PubMed
Summary
This summary is machine-generated.

Women with a history of breast cancer face a fivefold increased risk of developing a second primary breast cancer, primarily metachronous. Early detection and appropriate treatment lead to a favorable prognosis for secondary breast cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Internationalization of general surgical journals: origin and content of articles published in North America and Great Britain from 1983 to 1998.

Archives of surgery (Chicago, Ill. : 1960)·2001
Same author

Perforated duodenal ulcer: an alternative therapeutic plan.

Archives of surgery (Chicago, Ill. : 1960)·1998
Same author

Spontaneous hepatic hemorrhage associated with pregnancy. Treatment by hepatic arterial interruption.

Annals of surgery·1996
Same author

Choledochal cyst in the adult.

Annals of surgery·1995
Same author

Panel processes for revising relative values of physician work. A pilot study.

Medical care·1994
Same author

Pyogenic liver abscess. Modern treatment.

Archives of surgery (Chicago, Ill. : 1960)·1991
Same journal

Stepwise Solutions-Society.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Hospitals.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions for Providers.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Patients Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
Same journal

Post Hospital Surgical Disparities.

The Surgical clinics of North America·2026
Same journal

Inhospital Surgical Disparities.

The Surgical clinics of North America·2026
See all related articles

Area of Science:

  • Oncology
  • Breast Cancer Research
  • Clinical Medicine

Background:

  • A prior breast cancer diagnosis significantly elevates a woman's risk for a second primary breast cancer.
  • This secondary cancer can occur synchronously (at the same time) or metachronously (later).
  • Key risk factors include multifocal disease, lobular carcinoma in situ, and early-onset cancer with long survival.

Purpose of the Study:

  • To review the incidence, risk factors, detection, and management of second primary breast cancers.
  • To inform clinical practice regarding the follow-up and treatment of patients with a history of breast cancer.

Main Methods:

  • Literature review and synthesis of existing data on synchronous and metachronous breast cancers.
  • Analysis of risk factors, diagnostic modalities (mammography, biopsy), and treatment outcomes.

Related Experiment Videos

Main Results:

  • The majority of second primary breast cancers are metachronous, with an incidence of 5-6% compared to 1-2% for synchronous bilateral cancers.
  • Lobular carcinoma in situ is a strong marker for subsequent contralateral breast cancer.
  • Mammography aids in detecting synchronous cancers but doesn't alter overall incidence; routine random biopsy is not recommended.

Conclusions:

  • Long-term surveillance with physical examination and annual mammography is crucial for the contralateral breast.
  • Treatment for secondary breast cancer should be stage-appropriate.
  • Prognosis for a second primary breast cancer is generally favorable, contingent on the stage of both primary and secondary tumors.